We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNR icon
1076
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.72B
$319K ﹤0.01%
5,533
NTR icon
1077
Nutrien
NTR
$33.5B
$319K ﹤0.01%
6,634
-144
-2% -$6.94K
HGV icon
1078
Hilton Grand Vacations
HGV
$4.09B
$319K ﹤0.01%
8,778
-4,791
-35% -$186K
NVR icon
1079
NVR
NVR
$17.3B
$314K ﹤0.01%
32
+1
+3% +$8.73K
GIL icon
1080
Gildan
GIL
$9.48B
$314K ﹤0.01%
6,664
-788
-11% -$33.3K
SBLK icon
1081
Star Bulk Carriers
SBLK
$3.05B
$310K ﹤0.01%
13,105
HII icon
1082
Huntington Ingalls Industries
HII
$11.3B
$310K ﹤0.01%
1,174
+15
+1% +$3.97K
PFS icon
1083
Provident Financial Services
PFS
$3.14B
$309K ﹤0.01%
16,672
+802
+5% +$14.2K
CASS icon
1084
Cass Information Systems
CASS
$721M
$309K ﹤0.01%
7,453
+2,044
+38% +$84.6K
ITGR icon
1085
Integer Holdings
ITGR
$3.41B
$308K ﹤0.01%
+2,373
New +$290K
JXN icon
1086
Jackson Financial
JXN
$8.5B
$307K ﹤0.01%
3,362
+411
+14% +$34.3K
IYR icon
1087
iShares US Real Estate ETF
IYR
$4.73B
$304K ﹤0.01%
2,989
SMTC icon
1088
Semtech
SMTC
$9.67B
$304K ﹤0.01%
+6,660
New +$245K
FFIN icon
1089
First Financial Bankshares
FFIN
$5.07B
$304K ﹤0.01%
8,209
ACLX
1090
DELISTED
Arcellx
ACLX
$302K ﹤0.01%
+3,615
New +$241K
SGOL icon
1091
abrdn Physical Gold Shares ETF
SGOL
$6.85B
$302K ﹤0.01%
12,000
-1,750
-13% -$41.4K
HDB icon
1092
HDFC Bank
HDB
$122B
$301K ﹤0.01%
9,614
+334
+4% +$10.3K
MSEX icon
1093
Middlesex Water
MSEX
$1.07B
$300K ﹤0.01%
4,604
+80
+2% +$4.96K
USAC icon
1094
USA Compression Partners
USAC
$3.72B
$300K ﹤0.01%
13,100
B
1095
DELISTED
Barnes Group Inc.
B
$300K ﹤0.01%
7,430
+1,515
+26% +$59.7K
CBZ icon
1096
CBIZ
CBZ
$2.94B
$298K ﹤0.01%
4,425
+633
+17% +$46K
PB icon
1097
Prosperity Bancshares
PB
$8.92B
$294K ﹤0.01%
+4,085
New +$285K
DINO icon
1098
HF Sinclair
DINO
$16.2B
$294K ﹤0.01%
6,590
-155,273
-96% -$7.41M
SRPT icon
1099
Sarepta Therapeutics
SRPT
$1.65B
$292K ﹤0.01%
2,338
+47
+2% +$6.5K
ITA icon
1100
iShares US Aerospace & Defense ETF
ITA
$14B
$292K ﹤0.01%
1,950
+1,580
+427% +$223K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.